Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
72
CCJ Quote, Financials, Valuation and Earnings
Last price:
$77.91
Seasonality move
:
-1.74%
Day range:
$74.51 - $76.75
52-week range:
$35.00 - $76.75
Dividend yield:
0.15%
P/E ratio:
188.03x
P/S ratio:
14.09x
P/B ratio:
7.31x
Volume:
4.2M
Avg. volume:
5.9M
1-year change:
48.32%
Market cap:
$33.2B
Revenue:
$2.3B
EPS (TTM):
$0.41
Analysts' Opinion
-
Consensus RatingCameco has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $70.27, Cameco has an estimated downside of -7.31% from its current price of $76.19.
-
Price Target UpsideAccording to analysts, the highest upside price target is $79.67 representing -100% upside increase from its current price of $76.19.
Fair Value
-
According to the consensus of 12 analysts, Cameco has -7.31% downside to fair value with a price target of $70.27 per share.
CCJ vs. S&P 500
-
Over the past 5 trading days, Cameco has overperformed the S&P 500 by 6.42% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cameco does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cameco has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Cameco reported revenues of $549M.
Earnings Growth
-
Cameco has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cameco reported earnings per share of $0.11.
Enterprise value:
33.4B
EV / Invested capital:
--
Price / LTM sales:
14.09x
EV / EBIT:
98.31x
EV / Revenue:
14.19x
PEG ratio (5yr expected):
60.78x
EV / Free cash flow:
63.55x
Price / Operating cash flow:
63.10x
Enterprise value / EBITDA:
60.35x
Gross Profit (TTM):
$618.9M
Return On Assets:
2.58%
Net Income Margin (TTM):
7.5%
Return On Equity:
3.91%
Return On Invested Capital:
3.24%
Operating Margin:
23.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.9B | $2.4B | $469.7M | $549M | |
| Gross Profit | $263.7M | $430.9M | $618.9M | $138.5M | $187.8M | |
| Operating Income | $80M | $235.8M | $408.3M | $94.2M | $130.8M | |
| EBITDA | $369.2M | $480.9M | $554.1M | $74.3M | $145.5M | |
| Diluted EPS | $0.30 | $0.39 | $0.41 | -$0.01 | $0.11 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.8B | $2.5B | $1.1B | $1B | |
| Total Assets | $5.9B | $6B | $6.4B | $7B | $6.6B | |
| Current Liabilities | $187.8M | $347.8M | $323.3M | $764.5M | $387.5M | |
| Total Liabilities | $1.9B | $2.1B | $2B | $2.5B | $2B | |
| Total Equity | $3.9B | $3.9B | $4.4B | $4.5B | $4.5B | |
| Total Debt | $788.8M | $798.1M | $737.2M | $1.1B | $695.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $257.3M | $397.4M | $690.2M | $46.8M | $76.6M | |
| Cash From Investing | -$678.3M | -$1.8B | -$160.8M | -$29.7M | -$39.9M | |
| Cash From Financing | $668M | $347.7M | -$504.3M | -$200.7M | -$202.8M | |
| Free Cash Flow | $150.9M | $273.9M | $526.2M | $17.2M | $37.4M | |
CCJ
Sector
Market Cap
$33.2B
$57.4M
Price % of 52-Week High
99.27%
65.99%
Dividend Yield
0.15%
0%
Shareholder Yield
0.94%
4.75%
1-Year Price Total Return
48.32%
-23.9%
Beta (5-Year)
1.028
0.655
Dividend yield:
0.15%
Annualized payout:
$0.11
Payout ratio:
28.74%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$73.67
200-day SMA
Buy
Level
$52.85
Bollinger Bands (100)
Buy
Level
40.6 - 65.1
Chaikin Money Flow
Buy
Level
378.3M
20-day SMA
Buy
Level
$72.44
Relative Strength Index (RSI14)
Buy
Level
67.49
ADX Line
Buy
Level
52.31
Williams %R
Sell
Level
-7.5371
50-day SMA
Buy
Level
$63.11
MACD (12, 26)
Buy
Level
3.29
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
223.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.4305)
Buy
CA Score
(Annual)
Level (0.4198)
Buy
Beneish M-Score
(Annual)
Level (-3.1102)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.7839)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
Stock Forecast FAQ
In the current month, CCJ has received 11 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CCJ average analyst price target in the past 3 months is $70.27.
-
Where Will Cameco Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cameco share price will drop to $70.27 per share over the next 12 months.
-
What Do Analysts Say About Cameco?
Analysts are divided on their view about Cameco share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cameco is a Sell and believe this share price will rise from its current level to $56.77.
-
What Is Cameco's Price Target?
The price target for Cameco over the next 1-year time period is forecast to be $70.27 according to 12 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CCJ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cameco is a Buy. 11 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CCJ?
You can purchase shares of Cameco via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cameco shares.
-
What Is The Cameco Share Price Today?
Cameco was last trading at $77.91 per share. This represents the most recent stock quote for Cameco. Yesterday, Cameco closed at $76.19 per share.
-
How To Buy Cameco Stock Online?
In order to purchase Cameco stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
